These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15044649)

  • 21. Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders.
    Prescrire Int; 2007 Aug; 16(90):147. PubMed ID: 17724838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [5-Alpha reductase inhibitors--benign prostatic hypertrophy and much more].
    Holzgrabe U; Bennack E
    Pharm Unserer Zeit; 2008; 37(4):310-4. PubMed ID: 18570285
    [No Abstract]   [Full Text] [Related]  

  • 23. Benign prostatic hyperplasia: dihydrotestosterone and 5 alpha-reductase inhibition therapy.
    Imperato-McGinley J
    Prog Clin Biol Res; 1994; 386():197-203. PubMed ID: 7528387
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drugs against symptomatic, benign prostatic hyperplasia].
    Johansen TE
    Tidsskr Nor Laegeforen; 2002 Oct; 122(26):2544-5. PubMed ID: 12522881
    [No Abstract]   [Full Text] [Related]  

  • 25. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of finasteride in the treatment of hematuria associated with benign prostatic hypertrophy].
    Palou Redorta J; Gausa Gascon L; Salvador Bayarre J; Millán Rodríguez F; Segarra Tomás J; Villavicencio Mavrich H
    Arch Esp Urol; 2002 Oct; 55(8):895-9. PubMed ID: 12455279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finasteride for benign prostatic hyperplasia.
    Hasinski S; Miller JL; Rose LI
    Am Fam Physician; 1992 Nov; 46(5):1511-4. PubMed ID: 1279965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5alpha-reductase inhibitors.
    Rittmaster RS
    J Androl; 1997; 18(6):582-7. PubMed ID: 9432130
    [No Abstract]   [Full Text] [Related]  

  • 29. Finasteride for BPH.
    Johnson KH; Casey CM
    J Fam Pract; 1998 Jun; 46(6):455-6. PubMed ID: 9638104
    [No Abstract]   [Full Text] [Related]  

  • 30. Benign prostatic hyperplasia: from A - Z.
    Elhilali MM; Nickel JC
    Can J Urol; 2003 Apr; 10(2):1799-802. PubMed ID: 12773230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Finasteride to evaluate the efficacy of dutasteride in the management of patients with lower urinary tract symptoms and enlarged prostate.
    Ravish IR; Nerli RB; Amarkhed SS
    Arch Androl; 2007; 53(1):17-20. PubMed ID: 17364459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gynecomastia and breast cancer during finasteride therapy.
    Green L; Wysowski DK; Fourcroy JL
    N Engl J Med; 1996 Sep; 335(11):823. PubMed ID: 8778596
    [No Abstract]   [Full Text] [Related]  

  • 33. Finasteride treatment and neuroactive steroid formation.
    Dusková M; Hill M; Hanus M; Matousková M; Stárka L
    Prague Med Rep; 2009; 110(3):222-30. PubMed ID: 19655698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finasteride (Propecia) and the promotion of high-grade prostate cancer.
    Pitts WR
    Arch Dermatol; 2004 Jul; 140(7):885-6. PubMed ID: 15262708
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gynecomastia and finasteride].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2001 May; 128(5):691. PubMed ID: 11427816
    [No Abstract]   [Full Text] [Related]  

  • 36. [Using doxasosine and finasteride combination in the treatment of prostate adenoma].
    Bogdanov AB; Luk'ianov IV; Veliev EI
    Urologiia; 2006; (5):59-63. PubMed ID: 17444154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical predictors in the use of finasteride for control of gross hematuria due to benign prostatic hyperplasia.
    Kearney MC; Bingham J; Bergland R; Meade-D'Alisera P; Puchner PJ
    J Urol; 2002 Jun; 167(6):2489-91. PubMed ID: 11992064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cost-effectiveness aspects of benign prostatic hyperplasia (BPH) therapy].
    Lopatkin NA; Ziborova IV; Sivkov AV; Apolikhin OI
    Urol Nefrol (Mosk); 1999; (1):22-6. PubMed ID: 11149340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Finasteride in the treatment of benign prostatic hyperplasia.
    Ekman P; Andersen JT; Wolf H
    Acta Urol Belg; 1996 Mar; 64(1):IX-XII. PubMed ID: 8659328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thoughts on finasteride for benign prostatic hyperplasia.
    Anand A
    Am Fam Physician; 1993 Sep; 48(4):582, 588. PubMed ID: 7691035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.